ExCEEd Orphan logo — EXPERTS FOR ORPHAN DRUGS IN CENTRAL & EASTERN EUROPE

ExCEEd Orphan

EXPERTS FOR ORPHAN DRUGS IN CENTRAL & EASTERN EUROPE

Founded 2018 Czech Republic Czech Republic 23 employees Pharmaceutical

General Information

Company Name ExCEEd Orphan
Founded Year 2018
Location Czech Republic Czech Republic
Employees 23
Industries Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with ExCEEd Orphan. To contact ExCEEd Orphan, visit exceedorphan.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ExCEEd Orphan

ExCEEd Orphan is a trailblazing pharmaceutical startup that focuses on providing expert solutions for orphan drugs in Central & Eastern Europe. Founded in 2018 and headquartered in Czech Republic, the company boasts an international team of committed, knowledgeable, reliable, and enthusiastic pharmaceutical professionals with extensive experience in rare diseases. Their in-depth knowledge of local markets and processes, along with native proficiency in local languages, gives them a competitive edge. Additionally, ExCEEd Orphan has established profound contacts and strategic partnerships with key stakeholders and decision makers in the region. The company's industries of focus primarily lie within the pharmaceutical sector. One of their standout features is their proven and strong track record of successfully setting up and developing orphan drug businesses across Central & Eastern Europe. Despite the absence of specific recent investments, ExCEEd Orphan's dedication to addressing the unmet medical needs of rare disease patients in the region underscores its potential for attracting strategic investors. As the need for specialized treatments for orphan diseases continues to grow, ExCEEd Orphan is in a prime position to capitalize on these market opportunities and drive significant growth in the years to come.

Taxonomy: Orphan Drugs, Rare Diseases, Pharmaceutical Professionals, Central & Eastern Europe, Local Markets, Strategic Partnerships, Regulatory Expertise, Medical Distribution, Pharmacovigilance, Reimbursement, Commercialization, Rare Disease Medications, Expertise, International Operations

No funding data available for ExCEEd Orphan yet.

ExCEEd Orphan Alternatives & Competitors

ExCEEd Orphan vs
Komtur
Komtur Germany

Komtur delivers comprehensive healthcare solutions that connect pharmaceutical innovations with pati...

153 employees
Health Care, Pharmaceutical
ExCEEd Orphan vs

Your strategic partner in advancing patient health

Private Equity
81 employees
Biotechnology, Health Care
ExCEEd Orphan vs

Rare Diseases are only rare if you don't live with one.

Post-IPO Equity
5 employees
Biotechnology, Pharmaceutical

FAQ About ExCEEd Orphan

EXPERTS FOR ORPHAN DRUGS IN CENTRAL & EASTERN EUROPE
ExCEEd Orphan was founded in 2018.
ExCEEd Orphan is headquartered in Czech Republic.
ExCEEd Orphan operates in Pharmaceutical. Its work centres on Orphan Drugs, Rare Diseases, Pharmaceutical Professionals and Central & Eastern Europe.
ExCEEd Orphan has approximately 23 employees.
Top alternatives and competitors to ExCEEd Orphan include Komtur, TMC Pharma Services Ltd, Quoin Pharmaceuticals, GMEP Medical Technology GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ExCEEd Orphan and Komtur are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ExCEEd Orphan, https://bouncewatch.com/company/exceed-orphan, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes